Franco Cavaleri

Vivekananda Street
Koch Bihar, WB 736101, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Reevaluating the role of amyloid β-peptides in Alzheimer's disease: from pathogenic agents to protective chelation mechanisms.

Reevaluating the role of amyloid β-peptides in Alzheimer's disease: from pathogenic agents to protective chelation mechanisms.

Journal: Frontiers in neurology

Published: December 23, 2024

Study of Drug Targets Associated With Oncogenesis and Cancer Cell Survival and the Therapeutic Activity of Engineered Ashwagandha Extract Having Differential Withanolide Constitutions.

Study of Drug Targets Associated With Oncogenesis and Cancer Cell Survival and the Therapeutic Activity of Engineered Ashwagandha Extract Having Differential Withanolide Constitutions.

Journal: Integrative cancer therapies

Published: January 28, 2024

Study of Drug Target Identification and Associated Molecular Mechanisms for the Therapeutic Activity and Hair Follicle Induction of Two Ashwagandha Extracts Having Differential Withanolide Constitutions.

Study of Drug Target Identification and Associated Molecular Mechanisms for the Therapeutic Activity and Hair Follicle Induction of Two Ashwagandha Extracts Having Differential Withanolide Constitutions.

Journal: Journal of nutrition and metabolism

Published: March 22, 2023

Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health.

Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health.

Journal: Journal of nutrition and metabolism

Published: December 06, 2017

Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin.

Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin.

Journal: International journal of inflammation

Published: September 27, 2017

Corrigendum to "Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define proteomic events of the novel paradigm for Alzheimer's with metals as primary disease cause" [Med. Hypotheses 85 (2015) 779-790].

Corrigendum to "Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define proteomic events of the novel paradigm for Alzheimer's with metals as primary disease cause" [Med. Hypotheses 85 (2015) 779-790].

Journal: Medical hypotheses

Published: December 26, 2016

Corrigendum to "Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration" [Med. Hypotheses 84 (2015) 460-469].

Corrigendum to "Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration" [Med. Hypotheses 84 (2015) 460-469].

Journal: Medical hypotheses

Published: November 12, 2016

Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals as primary disease cause.

Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals as primary disease cause.

Journal: Medical hypotheses

Published: July 29, 2015

Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration.

Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration.

Journal: Medical hypotheses

Published: September 07, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026